Author

Dale R. Kopp

Pennsylvania State University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Molecular Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:E. coli· 2 Approach:experimental assay· 2

Frequent Co-Authors

Bimal JanaiD· 2 shared Kathleen PostleiD· 2 shared Hema Vakharia· 1 shared Mingchao Xie· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

4 top collaborators · 6 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMolecular Biology

Bimal JanaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Molecular BiologybioRxivPreprintJul 10, 2024

In vivo tests of the E. coli TonB system working model:interaction of ExbB with unknown proteins, identification of TonB-ExbD transmembrane heterodimers and PMF-dependent ExbD structures.

Kathleen Postle, Dale R. Kopp, Bimal Jana

The paper validates aspects of the TonB system working model through in vivo experiments, identifying new ExbB-interacting proteins and PMF-dependent ExbD conformational changes.

DOI 10.1101/2024.07.10.602958

E. coliexperimental assay

𝕏 PostBluesky

Molecular BiologybioRxivPreprintSep 26, 2022

Studies on the Escherichia coli ExbD Transmembrane Domain, Residue L132, and an Inhibitory Cyclic Peptide.

Bimal Jana, Dale R. Kopp, Mingchao Xie…·Kathleen Postle

This paper investigates the Escherichia coli ExbD transmembrane domain, identifies key residues for TonB system activity, and demonstrates that a cyclic peptide can inhibit ExbD-TonB interaction, suggesting a potential antimicrobial strategy.

1 citation

E. coliexperimental assay

𝕏 PostBluesky